Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type (1 selected)

Type

Guidance programme

HealthTech approach

HealthTech approach

Area of interest

Showing 1451 to 1475 of 2047

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancerTA347
Everolimus for preventing organ rejection in liver transplantationTA348
Secukinumab for treating moderate to severe plaque psoriasisTA350
Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal)TA351
Ultrasound‑enhanced, catheter‑directed thrombolysis for deep vein thrombosisHTG375
Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolismHTG376
Electrotherapy for the treatment of haemorrhoidsHTG377
Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headacheHTG378
Insertion of an epiretinal prosthesis for retinitis pigmentosaHTG372
Radiofrequency ablation for gastric antral vascular ectasiaHTG373
Suture fixation of acute disruption of the distal tibiofibular syndesmosisHTG374
Omalizumab for previously treated chronic spontaneous urticariaTA339
Vedolizumab for treating moderately to severely active ulcerative colitisTA342
Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolismTA341
Lower urinary tract symptoms in men: managementCG97
Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemiaTA343
Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challengesNG11
Violence and aggression: short-term management in mental health, health and community settingsNG10
Insertion of endobronchial nitinol coils to improve lung function in emphysemaHTG370
Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetesHTG371
Implantation of a left ventricular assist device for destination therapy in people ineligible for heart transplantationHTG369
Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndromeTA335
Empagliflozin in combination therapy for treating type 2 diabetesTA336
Rifaximin for preventing episodes of overt hepatic encephalopathyTA337
Excess winter deaths and illness and the health risks associated with cold homesNG6

Results per page

  1. 10
  2. 25
  3. 50
  4. All